Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, J. A.
Right arrow Articles by Raab-Traub, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, J. A.
Right arrow Articles by Raab-Traub, N.
[Cancer Research 64, 5251-5260, August 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma

Jennifer A. Morrison1, Margaret L. Gulley2, Rajadurai Pathmanathan4 and Nancy Raab-Traub1,3

Departments of 1 Microbiology and Immunology and 2 Pathology and Laboratory Medicine and 3 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, and 4 Subang Jaya Medical Centre, Selangor DE, Malaysia

EBV is associated with the epithelial cancer, nasopharyngeal carcinoma (NPC), and the lymphoid malignancy, Hodgkin lymphoma (HL). The EBV latent membrane proteins 1 and 2A are expressed in these tumors. These proteins activate the phosphatidylinositol 3'-OH kinase (PI3K)/Akt pathway, which is commonly activated inappropriately in malignancy. In this study, the status of Akt activation and its targets, glycogen synthase kinase-3ß (GSK-3ß) and ß-catenin, was investigated in NPC and HL clinical specimens. In the majority of HL and NPC specimens, Akt was activated, indicating an important role for this kinase in the development and/or progression of these tumors. Akt phosphorylates and inactivates GSK-3ß, a negative regulator of the proto-oncoprotein ß-catenin that is aberrantly activated in many cancers. GSK-3ß was phosphorylated and inactivated with concomitant nuclear ß-catenin accumulation in the majority of NPC specimens. The malignant cells of the majority of HL cases, however, did not have inactivated GSK-3ß and lacked nuclear ß-catenin expression. These data indicate that this signaling arm of PI3K/Akt is universal and important in NPC pathogenesis but is apparently not affected in HL. These findings point to a divergence in pathways activated by EBV in different cellular contexts.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. H.Y. Shair, C. I. Schnegg, and N. Raab-Traub
EBV Latent Membrane Protein 1 Effects on Plakoglobin, Cell Growth, and Migration
Cancer Res., September 1, 2008; 68(17): 6997 - 7005.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-R. Chen, M.-T. Liu, Y.-T. Chang, C.-C. Wu, C.-Y. Hu, and J.-Y. Chen
Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial Cells
J. Virol., August 15, 2008; 82(16): 8124 - 8137.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Fukuda and R. Longnecker
Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway
J. Virol., September 1, 2007; 81(17): 9299 - 9306.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nagel, C. Burek, L. Venturini, M. Scherr, H. Quentmeier, C. Meyer, A. Rosenwald, H. G. Drexler, and R. A. F. MacLeod
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1
Blood, April 1, 2007; 109(7): 3015 - 3023.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
S. D. Hayward, J. Liu, and M. Fujimuro
Notch and Wnt Signaling: Mimicry and Manipulation by Gamma Herpesviruses
Sci. Signal., May 16, 2006; 2006(335): re4 - re4.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Pegtel, A. Subramanian, T.-S. Sheen, C.-H. Tsai, T. R. Golub, and D. A. Thorley-Lawson
Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis
J. Virol., December 15, 2005; 79(24): 15430 - 15442.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Fujimuro, J. Liu, J. Zhu, H. Yokosawa, and S. D. Hayward
Regulation of the Interaction between Glycogen Synthase Kinase 3 and the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen
J. Virol., August 15, 2005; 79(16): 10429 - 10441.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. N. Everly Jr., S. Kusano, and N. Raab-Traub
Accumulation of Cytoplasmic {beta}-Catenin and Nuclear Glycogen Synthase Kinase 3{beta} in Epstein-Barr Virus-Infected Cells
J. Virol., November 1, 2004; 78(21): 11648 - 11655.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.